X-38154583-G-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The ENST00000378533.4(SRPX):c.1090C>A(p.Gln364Lys) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0001 in 1,205,933 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 36 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000378533.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SRPX | NM_006307.5 | c.1090C>A | p.Gln364Lys | missense_variant, splice_region_variant | 9/10 | ENST00000378533.4 | NP_006298.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SRPX | ENST00000378533.4 | c.1090C>A | p.Gln364Lys | missense_variant, splice_region_variant | 9/10 | 1 | NM_006307.5 | ENSP00000367794 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000116 AC: 13AN: 111660Hom.: 0 Cov.: 23 AF XY: 0.0000591 AC XY: 2AN XY: 33814
GnomAD3 exomes AF: 0.0000693 AC: 12AN: 173271Hom.: 0 AF XY: 0.0000683 AC XY: 4AN XY: 58575
GnomAD4 exome AF: 0.0000987 AC: 108AN: 1094273Hom.: 0 Cov.: 30 AF XY: 0.0000945 AC XY: 34AN XY: 359967
GnomAD4 genome AF: 0.000116 AC: 13AN: 111660Hom.: 0 Cov.: 23 AF XY: 0.0000591 AC XY: 2AN XY: 33814
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.1090C>A (p.Q364K) alteration is located in exon 9 (coding exon 9) of the SRPX gene. This alteration results from a C to A substitution at nucleotide position 1090, causing the glutamine (Q) at amino acid position 364 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at